Boji Medical TechnologyLtd マネジメント

マネジメント基準チェック /44

Boji Medical TechnologyLtdの CEO はTingchun Wangで、 Jun2011年に任命され、の在任期間は 13.42年です。は、会社の株式の31.27%を直接所有しており、その価値はCN¥ 1.06B 。経営陣と取締役会の平均在任期間はそれぞれ9.5年と4.3年です。

主要情報

Tingchun Wang

最高経営責任者

CN¥414.0k

報酬総額

CEO給与比率	n/a
CEO在任期間	13.4yrs
CEOの所有権	31.3%
経営陣の平均在職期間	9.5yrs
取締役会の平均在任期間	4.3yrs

経営陣の近況

Recent updates

We Don’t Think Boji Medical TechnologyLtd's (SZSE:300404) Earnings Should Make Shareholders Too Comfortable

Nov 02

A Piece Of The Puzzle Missing From Boji Medical Technology Co.,Ltd.'s (SZSE:300404) 39% Share Price Climb

Oct 08

Boji Medical TechnologyLtd's (SZSE:300404) Profits Appear To Have Quality Issues

May 01

Further Upside For Boji Medical Technology Co.,Ltd. (SZSE:300404) Shares Could Introduce Price Risks After 35% Bounce

Mar 06

CEO（最高経営責任者

Tingchun Wang (59 yo)

13.4yrs

在職期間

CN¥414,000

報酬

Mr. Tingchun Wang, M.D. & Ph D., is a Founder of Boji Medical Technology Co.,Ltd. and has been its General Manager and Chairman since June 11, 2011.Mr. Wang serves as Member of the Board at Guangzhou Funw...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Tingchun Wang	Founder	13.4yrs	CN¥414.00k	31.27% CN¥ 1.1b
Xiu Qing Ou	Deputy GM & CFO	13.4yrs	CN¥461.80k	0.099% CN¥ 3.3m
Quan Zhu	Deputy GM & Director	9.5yrs	CN¥1.44m	0.077% CN¥ 2.6m
Bo Tan	Deputy GM & Director	9.5yrs	CN¥937.60k	0.072% CN¥ 2.4m
Yu Ping Han	Deputy General Manager	no data	CN¥865.90k	0.072% CN¥ 2.4m
Shaobo Wen	Deputy General Manager	3.6yrs	CN¥1.27m	0.019% CN¥ 631.0k
Lian Zuo	Deputy General Manager	2.9yrs	CN¥1.20m	0.011% CN¥ 374.4k
Zhanpeng Chen	Accounting Supervisor	no data	データなし	データなし

9.5yrs

平均在職期間

51yo

平均年齢

経験豊富な経営陣: 300404の経営陣は経験豊富で経験豊富です（平均在職期間は9.5年）。

取締役

名称	ポジション	在職期間	報酬	所有権
Tingchun Wang	Founder	13.4yrs	CN¥414.00k	31.27% CN¥ 1.1b
Quan Zhu	Deputy GM & Director	9.5yrs	CN¥1.44m	0.077% CN¥ 2.6m
Bo Tan	Deputy GM & Director	9.5yrs	CN¥937.60k	0.072% CN¥ 2.4m
Kejian Zhang	Director	4.3yrs	CN¥84.00k	データなし
Qing Chen	Independent Director	4.3yrs	CN¥84.00k	データなし
Wang Fang	Supervisor	4.3yrs	データなし	データなし
Kang Xie	Independent Director	2.5yrs	CN¥84.00k	データなし
Huayi Li	Independent Director	1.3yrs	CN¥35.00k	データなし
Peidan Xian	Non-Employee Supervisor	1.3yrs	データなし	データなし

4.3yrs

平均在職期間

52yo

平均年齢

経験豊富なボード: 300404の取締役会は経験豊富であると考えられます ( 4.3年の平均在任期間)。

Boji Medical TechnologyLtd マネジメント

マネジメント 基準チェック /44

主要情報

経営陣の近況

Boji Medical Technology Co.,Ltd., Annual General Meeting, May 16, 2024

High number of new directors

Boji Medical Technology Co., Ltd. Approves the Election of Directors and Non-Employee Supervisors

Less than half of directors are independent

Insufficient new directors

Recent updates

We Don’t Think Boji Medical TechnologyLtd's (SZSE:300404) Earnings Should Make Shareholders Too Comfortable

Third quarter 2024 earnings released: EPS: CN¥0.034 (vs CN¥0.015 in 3Q 2023)

A Piece Of The Puzzle Missing From Boji Medical Technology Co.,Ltd.'s (SZSE:300404) 39% Share Price Climb

Boji Medical Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 26, 2024

Second quarter 2024 earnings released: EPS: CN¥0.036 (vs CN¥0.016 in 2Q 2023)

Boji Medical Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 27, 2024

New minor risk - Profit margin trend

Boji Medical TechnologyLtd's (SZSE:300404) Profits Appear To Have Quality Issues

Boji Medical Technology Co., Ltd. Announces Profit Distribution Proposal for 2023

Boji Medical Technology Co.,Ltd., Annual General Meeting, May 16, 2024

First quarter 2024 earnings released: EPS: CN¥0.043 (vs CN¥0.032 in 1Q 2023)

Boji Medical Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 25, 2024

Further Upside For Boji Medical Technology Co.,Ltd. (SZSE:300404) Shares Could Introduce Price Risks After 35% Bounce

New minor risk - Share price stability

Boji Medical Technology Co., Ltd. (SZSE:300404) announces an Equity Buyback for CNY 20 million worth of its shares.

Investor sentiment deteriorates as stock falls 25%

Boji Medical Technology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 25, 2024

New minor risk - Shareholder dilution

Third quarter 2023 earnings released: EPS: CN¥0.015 (vs CN¥0.018 in 3Q 2022)

Boji Medical Technology Co., Ltd. to Report Q3, 2023 Results on Oct 27, 2023

High number of new directors

Second quarter 2023 earnings released: EPS: CN¥0.016 (vs CN¥0.007 in 2Q 2022)

Boji Medical Technology Co., Ltd. Approves the Election of Directors and Non-Employee Supervisors

Boji Medical Technology Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 11 July 2023

First quarter 2023 earnings released: EPS: CN¥0.032 (vs CN¥0.034 in 1Q 2022)

Boji Medical Technology Co., Ltd. announced a financing transaction

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.018 (vs CN¥0.052 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.007 (vs CN¥0.021 in 2Q 2021)

Boji Medical Technology Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date Is 02 June 2022

Boji CRO Approves Cash Dividend for the Year 2021

Boji Medical Technology Co., Ltd. Proposes Final Cash Dividend for 2021

First quarter 2022 earnings released: EPS: CN¥0.048 (vs CN¥0.033 in 1Q 2021)

Insufficient new directors

Third quarter 2021 earnings released: EPS CN¥0.074 (vs CN¥0.034 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.03 (vs CN¥0.078 in 2Q 2020)

Guangzhou Boji Medical & Biotechnological Co., Ltd. Approves Cash Dividend for 2020

First quarter 2021 earnings released: EPS CN¥0.033 (vs CN¥0.026 loss in 1Q 2020)

New 90-day low: CN¥10.50

New 90-day low: CN¥12.13

Third quarter earnings released

Guangzhou Boji Medical & Biotechnological Co., Ltd. to Report Q3, 2020 Results on Oct 28, 2020

New 90-day low: CN¥12.61

First half earnings released

New 90-day low - CN¥14.19

Guangzhou Boji Medical & Biotechnological Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

New 90-day high - CN¥17.57

CEO（最高経営責任者

在職期間

報酬

リーダーシップ・チーム

平均在職期間

平均年齢

取締役

平均在職期間

平均年齢

マネジメント基準チェック /44